AddParts, a UK-based technology company enabling pharmaceutical manufacturers to improve production continuity and reduce operational risk, has secured a six-figure ...

Takara Bio and Resistomap Oy today announce a strategic agreement to deepen their partnership in developing streamlined end-to-end solutions for high throughput anti...

Ofichem has brought its brands - Ofichem BV, Ofipharma, Ofimedicine, Labatorium Ofichem, Ofichem Uppsala, and Avivia - together as one family-owned CDMO and pharmace...

Dr. Al Mutar brings deep expertise in gastrointestinal oncology and early-phase clinical trials and will help to expand access to innovative therapies across North T...

he Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has inaugurated the Abu Dhabi Biobank, an integrated platform devel...

Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces that its new state-of –the-art GLP bioanalytical ...

Aragen, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) launched ChemiSHE, a first-of-its-kind chemistry synthesis labor...

 Advances in biologics and peptide therapeutics continue to drive innovation in drug delivery and molecular design. Among the enabling technologies supporting t...

Lonza, one of the world’s largest contract development and manufacturing organisations (CDMOs), today announced the launch of its Media Development Lab at its Singap...

Symeres, a leading CRDMO for drug discovery and development has partnered with Ambagon Therapeutics, a pre-clinical biotechnology company, to explore a new class of ...